OpenURL Connection Search

Select item for more details and to access through your institution.

A pathologic assessment of tumor residue and stromal changes after intraarterial chemotherapy for head and neck carcinomas. A study on serial sections of the whole surgical specimen.
Published in:
1989
By:
- Sulfaro, Sandro;
- Frustaci, Sergio;
- Volpe, Rachele;
- Barzan, Luigi;
- Comoretto, Roberto;
- Monfardini, Silvio;
- Carbone, Antonino;
- Sulfaro, S;
- Frustaci, S;
- Volpe, R;
- Barzan, L;
- Comoretto, R;
- Monfardini, S;
- Carbone, A
Publication type:
journal article
Intermittent pelvic arterial infusion with peptichemio, doxorubicin, and cisplatin for locally advanced and recurrent carcinoma of the uterine cervix.
Published in:
1987
By:
- Scarabelli, Carlo;
- Tumolo, Salvatore;
- De Paoli, Antonino;
- Frustaci, Sergio;
- Campagnutta, Elio;
- Morassut, Sandro;
- Franchin, Gianni;
- Crivellari, Diana;
- Sopracordevole, Francesco;
- Lo Re, Giovanni;
- Grigoletto, Eligio;
- Monfardini, Silvio;
- Scarabelli, C;
- Tumolo, S;
- De Paoli, A;
- Frustaci, S;
- Campagnutta, E;
- Morassut, S;
- Franchin, G;
- Crivellari, D
Publication type:
journal article
Intra-arterial continuous infusion of cis-diamminedichloroplatinum in untreated head and neck cancer patients.
Published in:
1986
By:
- Frustaci, Sergio;
- Barzan, Luigi;
- Tumolo, Salvatore;
- Comoretto, Roberto;
- Quadu, Giovanni;
- Galligioni, Enzo;
- Lorenzini, Manlio;
- Crivellari, Diana;
- Caruso, Giuseppe;
- Piccinin, Giampaolo;
- Veronesi, Andrea;
- Tirelli, Umberto;
- Grigoletto, Eligio;
- Frustaci, S;
- Barzan, L;
- Tumolo, S;
- Comoretto, R;
- Quadu, G;
- Galligioni, E;
- Lorenzini, M
Publication type:
journal article
Local neurotoxicity of Cisplatin after intra-arterial chemotherapy.
Published in:
Acta Neurologica Scandinavica, 1986, v. 73, n. 3, p. 302, doi. 10.1111/j.1600-0404.1986.tb03281.x
By:
- Pomes, A.;
- Frustaci, S.;
- Cattaino, G.;
- Grandis, D.;
- Bongiovanni, L. G.;
- Tumolo, S.;
- Quadu, G.
Publication type:
Article
Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial.
Published in:
2011
By:
- Celio L;
- Frustaci S;
- Denaro A;
- Buonadonna A;
- Ardizzoia A;
- Piazza E;
- Fabi A;
- Capobianco AM;
- Isa L;
- Cavanna L;
- Bertolini A;
- Bichisao E;
- Bajetta E;
- Italian Trials in Medical Oncology Group;
- Celio, Luigi;
- Frustaci, Sergio;
- Denaro, Angela;
- Buonadonna, Angela;
- Ardizzoia, Antonio;
- Piazza, Elena
Publication type:
journal article
Non-linear pharmacokinetics of high-dose intravenous verapamil.
Published in:
British Journal of Clinical Pharmacology, 1997, v. 44, n. 3, p. 255, doi. 10.1046/j.1365-2125.1997.t01-1-00574.x
By:
- Toffoli, G.;
- Robieux, I.;
- Fantin, D.;
- Gigante, M.;
- Frustaci, S.;
- Nicolosi, G. L.;
- De Cicco, M.;
- Boiocchi, M.
Publication type:
Article
A phase 2 trial of imatinib mesylate in patients with recurrent nonresectable chondrosarcomas expressing platelet-derived growth factor receptor-[alpha] or -[beta]: An Italian Sarcoma Group study.
Published in:
2011
By:
- Grignani G;
- Palmerini E;
- Stacchiotti S;
- Boglione A;
- Ferraresi V;
- Frustaci S;
- Comandone A;
- Casali PG;
- Ferrari S;
- Aglietta M
Publication type:
Journal Article

Found: 7

A pathologic assessment of tumor residue and stromal changes after intraarterial chemotherapy for head and neck carcinomas. A study on serial sections of the whole surgical specimen.

Intermittent pelvic arterial infusion with peptichemio, doxorubicin, and cisplatin for locally advanced and recurrent carcinoma of the uterine cervix.

Intra-arterial continuous infusion of cis-diamminedichloroplatinum in untreated head and neck cancer patients.

Local neurotoxicity of Cisplatin after intra-arterial chemotherapy.

Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial.

Non-linear pharmacokinetics of high-dose intravenous verapamil.

A phase 2 trial of imatinib mesylate in patients with recurrent nonresectable chondrosarcomas expressing platelet-derived growth factor receptor-[alpha] or -[beta]: An Italian Sarcoma Group study.